Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer

被引：0
|
作者：
Shuangjie Liu
Zhuonan Liu
Chiyuan Piao
Zhe Zhang
Chuize Kong
Lei Yin
Xi Liu
机构：
[1] The First Hospital of China Medical University,Department of Urology
来源：
Journal of Experimental & Clinical Cancer Research | / 41卷
关键词：
Protein arginine methyltransferase; Flavokawain A; Bladder cancer; Methylation disorder; Arginine methylation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] PRMT5 promotes retinoblastoma development
    Jiang, Yu
    Zheng, Guangying
    Sun, Xiantao
    HUMAN CELL, 2023, 36 (01) : 329 - 341
  • [32] PRMT5: splicing up tolerance
    Kumar, Rathan
    Ranganathan, Parvathi
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (20):
  • [33] PRMT5 promotes retinoblastoma development
    Yu Jiang
    Guangying Zheng
    Xiantao Sun
    Human Cell, 2023, 36 : 329 - 341
  • [34] DEVELOPMENT A new move for PRMT5
    Huddleston, Joanna E.
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2011, 12 (02) : 76 - 76
  • [35] Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
    Smith, James M.
    Barlaam, Bernard
    Beattie, David
    Bradshaw, Lauren
    Chan, Ho Man
    Chiarparin, Elisabetta
    Collingwood, Olga
    Cooke, Sophie L.
    Cronin, Anna
    Cumming, Iain
    Dean, Emma
    Debreczeni, Judit E.
    del Barco Barrantes, Ivan
    Diene, Coura
    Gianni, Davide
    Guerot, Carine
    Guo, Xiaoxiao
    Guven, Sinem
    Hayhow, Thomas G.
    Hong, Ted
    Kemmitt, Paul D.
    Lamont, Gillian M.
    Lamont, Scott
    Lynch, James T.
    McWilliams, Lisa
    Moore, Shaun
    Raubo, Piotr
    Robb, Graeme R.
    Robinson, James
    Scott, James S.
    Srinivasan, Bharath
    Steward, Oliver
    Stubbs, Christopher J.
    Syson, Karl
    Tan, Lixiang
    Turner, Oliver
    Underwood, Elizabeth
    Urosevic, Jelena
    Vazquez-Chantada, Mercedes
    Whittaker, Amy L.
    Wilson, David M.
    Winter-Holt, Jon J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (16) : 13604 - 13638
  • [36] PRMT5 activates KLF5 by methylation to facilitate lung cancer
    Zhou, Hai
    Chang, Jing
    Zhang, Jingjian
    Zheng, Hongzhen
    Miao, Xiang
    Mo, Huimin
    Sun, Jie
    Jia, Qin
    Qi, Guangsheng
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (05)
  • [37] JBI-778, a novel brain-penetrant small molecule PRMT5 inhibitor for treatment of cancer
    Sivanandhan, Dhanalakshmi
    Gajendran, Chandru
    Sadhu, Naveen M.
    Mohammed, Zainuddin
    Gosu, Ramachandraiah
    Sher, Divsha
    Mansur, Shahar
    Friedmann-Morvinski, Dinorah
    Rajagopal, Sridharan
    Rastelli, Luca
    CANCER RESEARCH, 2023, 83 (07)
  • [38] HSK41959-2: An oral MTA-cooperative PRMT5 inhibitor for MTAP deleted cancer
    Yan, Pangke
    Wang, Ju
    Qian, Meilin
    Yu, Xiaojuan
    Li, Yao
    Zhang, Haoliang
    Tao, Lihua
    Kou, Rui
    Hu, Teng
    Tang, Pingming
    Dong, Hongjiao
    Wu, Aipin
    He, Maotao
    CANCER RESEARCH, 2024, 84 (06)
  • [39] Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue
    Prabhu, Lakshmi
    Martin, Matthew
    Chen, Lan
    Demir, Ozlem
    Jin, Jiamin
    Huang, Xiumei
    Motolani, Aishat
    Sun, Mengyao
    Jiang, Guanglong
    Nakshatri, Harikrishna
    Fishel, Melissa L.
    Sun, Steven
    Safa, Ahmad
    Amaro, Rommie E.
    Kelley, Mark R.
    Liu, Yunlong
    Zhang, Zhong-Yin
    Lu, Tao
    GENES & DISEASES, 2023, 10 (01) : 267 - 283
  • [40] LKB1 regulates PRMT5 activity in breast cancer
    Lattouf, Hanine
    Kassem, Loay
    Jacquemetton, Julien
    Choucair, Ali
    Poulard, Coralie
    Tredan, Olivier
    Corbo, Laura
    Diab-Assaf, Mona
    Hussein, Nader
    Treilleux, Isabelle
    Le Romancer, Muriel
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (03) : 595 - 606
12345